Vanguard Value ETF (VTV)
124.68
-2.29 (-1.80%)
USD |
NYSEARCA |
Sep 29, 14:41
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.04% | 0.00% | 91.02B | 2.481M |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 2.72% | 9.00% | 19.26B | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of the CRSP US Large Cap Value Index that measures the investment return of large-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| CRSP US Large Cap Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Gerard O’Reilly | 27.69 yrs |
| Walter Nejman | 6.35 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
1
19.26B
-6.318B
Category Low
19.26B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of August 31, 2022
Performance Versus Category
As of September 28, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of September 28, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 2.96% | 504.96 | -1.75% |
| Berkshire Hathaway Inc Class B | 2.95% | 268.70 | -1.13% |
| Johnson & Johnson | 2.58% | 164.38 | -1.19% |
| Exxon Mobil Corp | 2.45% | 88.54 | -0.36% |
| JPMorgan Chase & Co | 2.03% | 105.88 | -1.95% |
| Procter & Gamble Co | 2.01% | 128.84 | -2.38% |
| Chevron Corp | 1.70% | 144.26 | -1.04% |
| Eli Lilly and Co | 1.57% | 328.57 | -1.74% |
| Pfizer Inc | 1.54% | 44.10 | -0.74% |
| Coca-Cola Co | 1.46% | 56.15 | -1.46% |
News
Headline
Wire
Time (ET)
SA Breaking News
03/21 08:18
SA Breaking News
12/30 12:41
SA Breaking News
12/13 10:42
SA Breaking News
06/30 09:17
SA Breaking News
06/02 09:33
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of the CRSP US Large Cap Value Index that measures the investment return of large-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| CRSP US Large Cap Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Gerard O’Reilly | 27.69 yrs |
| Walter Nejman | 6.35 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (9-29-22) | 2.72% |
| 30-Day SEC Yield (9-27-22) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 15.40 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of August 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 1/26/2004 |
| Last Annual Report Date | 12/31/2021 |
| Last Prospectus Date | 4/29/2022 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
SA Breaking News
03/21 08:18
SA Breaking News
12/30 12:41
SA Breaking News
12/13 10:42
SA Breaking News
06/30 09:17
SA Breaking News
06/02 09:33